Markets failed to rally despite what analysts said was a clear win for the European pharmaceutical sector in a trade update Thursday.
Get this delivered to your inbox, and more info about our products and services.
Drugmakers rally after Pfizer agreement as Most Favored Nation plans still loom over sector.
A number of global pharma firms have pulled or paused U.K. investment plans amid waning government support and drug pricing talks.
Several European firms have downgraded their guidance due to the impact of White House trade policies.
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…
Investors didn't see the change as a major sell-the-news event.
A resurgence in trade tensions between the U.S. and China squeezed some of the excess out of an enthusiastic market and put…
